References
- Ace C I, McKee T A, Ryan J M, Preston C M. Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate‐early gene expression. J Virol 1989; 63: 2260–2269
- Block T M, Deshmane S, Masonis J, Maggioncalda J, Valyi‐Nagi T, Fraser N W. An HSV LA null mutant reactivates slowly from latent infection and makes small lacques on CV‐1 monolayers. Virology 1994; 192: 618–630
- Chiocca E A, Choi B B, Cai W Z, Deluca N A, Schaffer P A, Diflglia M, Breakefield X O, Matuza R L. Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants. New Biology 1990; 2: 739–746
- Danaher R J, Jacob R J, Miller C S. Establishment of a quiescent herpes simplex virus type 1 infection in neurally‐differentiated PC12 cells. J Neurovirol 1999; 5: 258–267
- Deatly A M, Spivack J G, Lavi E, Fraser N W. RNA from an immediate early region of the HSV‐1 genome is present in the trigeminal ganglia of latently infected mice. Proc Natl Acad Sci USA 1987; 84: 3204–3208
- Ecob‐Prince M S, Preston C M, Rixon F J, Hassan K, Kennedy P G E. Neurons containing latency‐associated transcripts are numerous and wildspread in dorsal root ganglis following footpad inoculation of mice with herpes simplex virus type 1 mutant in 1814. J Gen Virol 1993; 74: 985–994
- Fraser N W, Spivack J G, Wroblewska Z, Block T M, Deshmane S L, Valyi‐Nagy T, Natarajan R, Gesser R. A review of the molecular mechanism of HSV‐1 latency. Curr Eye Res 1991; 10: 1–14
- Fraser N W, Valyi‐Nagy T. Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation. Microb Pathog 1993; 15: 83–91
- Greene L A, Rukenstein A. The quantitative bioassay of nerve growth factor with PC12 cells. Aferve Growth Factors, R A Rush. John Wiley, New York 1989; 139–147
- Greene L A, Tischler A S. Establishment of a nonadrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 1976; 73: 2424–2428
- Hay K A, Gaydos A, Tenser R B. The role of herpes simplex thymidine kinase expression in neuroviru‐lence and latency in newborn vs adult mice. J Neuroimmunol 1995; 61: 41–52
- Harris R A, Everett R D, Zhu X X, Silverstein S, Preston C M. Herpes simplex virus type 1 immediate‐early protein Vmw 110 reactivates latent herpes simplex virus type 2 in an in vitro latency system. J Virol 1989; 63: 3513–3515
- Harris R A, Preston C M. Establishment of latency in vitro by the herpes simplex virus type 1 mutant in 1814. J Gen Virol 1991; 72: 907–913
- Honess R W, Roizman B. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol 1974; 14: 8–19
- Honess R W, Roizman B. Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides. Proc Natl Acad Sci USA 1975; 72: 1276–1280
- Huang Q S, Deshmane S L, Fraser N W. An in vitro ligation and transfection system for inserting DNA sequences into the latency‐associated transcripts (LATs) gene of herpes simplex virus type 1. Gene Ther 1994; 1: 300–306
- Le Maire M, Jorgensen K E, Roigaard‐Peterson H, Moller J V. Properties of deoxycholate solubilized sarcoplasmic reticulum Ca2+ ATPase. Biochemistry 1976; 15: 5805–5812
- Lieb D A, Coen D M, Bogard C L, Hicks K A, Yager D R, Knipe D M, Tyler K L, Schaffer P A. Immediate‐early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol 1989; 63: 759–768
- Mitchell W J. Neurons differentially control expression of a herpes simplex virus type 1 immediate‐early promoter in transgenic mice. J Virol 1995; 69: 7942–7950
- Nishiyama Y, Kurachi R, Daikoku T, Umene K. The US 9, 10, 11, and 12 genes of herpes simplex virus type 1 are of no importance for its neuroviru‐lence and latency in mice. Virology 1993; 194: 419–423
- Roizman B, Sears A E. Herpes simplex viruses and their replication. Fundamental virology, B N Fields, D M Knipe. Raven Press Ltd., New York 1996; 2231–2296
- Russell J, Preston C M. An in vitro latency system for herpes simplex type 2. J Gen Virol 1986; 67: 397–403
- Sanes J R, Rubenstein J L, Nicholas J F. Use of a recombinant retrovirus to study post‐implantation cell lineage in mouse embryos. EMBO J 1986; 5: 3133–3142
- Sedarati N M, Margolis T P, Stevens J G. Latent infection can be established with drastically restricted transcription and replication of the HSV‐1 genome. Virology 1993; 192: 687–691
- Stow E C, Stow N D. Complementation of a herpes simplex virus type 1 VmwllO deletion mutant by human cytomegalovirus. J Gen Virol 1989; 70: 695–704
- Stevens J G, Wagner E K, Devi‐Rao G B, Cook M L, Feldman L T. RNA complementary to a herpes virus gene mRNA is prominent in latently infected neurons. Science 1987; 235: 1056–1059
- Stevens J G. Human herpesviruses: a consideration of the latent state. Microbiol Bev 1989; 53: 318–332
- Su Y H, Meegalla R L, Chowhan R, Cubitt C, Oakes J E, Lausch R L, Fraser N W, Block T M. Human corneal cells and other fibroblasts can stimulate the app earance of herpes simplex virus from quiescently infected PC12 cells. J Virol 1999; 73: 4171–4180
- Wagner E K, Bloom D C. Experimental investigation of herpes simplex virus latency. Clin Micro Bev 1997; 10: 419–443
- Zhu X, Chen J, Young C S H, Silverstein S. Reactivation of latent Herpes Simplex Virus by Adenovirus recombinants encoding mutant IE‐0 gene products. J Virol 1990; 64: 4489–4498